Clinical Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation With Different Modes on Parkinson's Disease
NCT07176091 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2026-02-13
Summary
TMS regulates cortical excitability through electromagnetic induction, with low-frequency stimulation suppressing and high-frequency stimulation enhancing excitability. Building on theta-gamma coupling, iTBS induces broader improvements in functional brain connectivity within a shorter stimulation period, particularly by significantly reducing abnormal variability in the prefrontal and parietal regions, demonstrating superior neuromodulatory efficiency and network remodeling capacity. This study aims to compare the symptomatic effects of different iTBS protocols on Parkinson's disease, optimize stimulation parameters, and evaluate safety, while also analyzing the time-dependent trends of therapeutic efficacy through 1- and 3-month follow-ups.
Conditions
- Parkinsonism
- Transcranial Magnetic Stimilation
- Intermittent Theta Burst Stimulation
- Primary Motor Cortex
- Electroencephalography
- Neuromodulation
Interventions
- PROCEDURE
-
High-dose iTBS treatment group
The stimulation intensity is 80% of the resting motor threshold (RMT), with an intra-burst frequency of 50 Hz and an inter-burst frequency of 5 Hz. Each train lasts 2 seconds, followed by an 8-second inter-train interval, delivering 1,800 pulses per session. The session is repeated after a 30-minute interval, with a total of 5 sessions per day (amounting to 9,000 pulses daily). Stimulation is administered for 5 consecutive days, resulting in a total of 45,000 pulses.
- PROCEDURE
-
Low-dose iTBS treatment group
The stimulation intensity is 80% of the resting motor threshold (RMT), with an intra-burst frequency of 50 Hz and an inter-burst frequency of 5 Hz. Each train lasts 2 seconds, followed by an 8-second inter-train interval, delivering 1,800 pulses per session. Stimulation is administered once daily (1,800 pulses per day) for 5 consecutive days, resulting in a total of 9,000 pulses.
- PROCEDURE
-
Sham stimulation group
The intervention procedure is identical to that of active stimulation, with the sole difference being the use of a specific sham coil. This sham coil has the same appearance as the active coil but is specially modified to produce no magnetic field, generating only vibration and sound.
Sponsors & Collaborators
-
Second Affiliated Hospital of Soochow University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2027-03-01
- Completion
- 2027-06-01
Countries
- China
Study Locations
More Related Trials
-
Clinical Trail of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Upper Limb Bradykinesia in Parkinson' Disease' Patients
NCT06641193 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Multicenter Clinical Study of rTMS for Parkinson's Disease
NCT06009471 ·Status: UNKNOWN ·Phase: NA
-
Navigated Repetitive Transcranial Magnetic Stimulation for Parkinson's Disease With Depression or Cognitive Impairment
NCT04707378 ·Status: UNKNOWN ·Phase: NA
-
Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease
NCT00001665 ·Status: COMPLETED
-
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
NCT06002581 ·Status: RECRUITING ·Phase: NA
-
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Parkinson Disease
NCT02969941 ·Status: COMPLETED ·Phase: NA
-
Transcranial Magnetic Stimulation to Treat Parkinson's Disease
NCT00753519 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
TDCS-RTMS Intervention for Motor Function
NCT07257601 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Transcranial Direct Current Stimulation for Treating Parkinson´s Disease-related Pain in OFF State
NCT06214377 ·Status: COMPLETED ·Phase: NA
-
Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients
NCT06350617 ·Status: RECRUITING ·Phase: NA
-
Investigating the Safety of srTMS in the Treatment of Parkinson's Disease
NCT00063284 ·Status: COMPLETED ·Phase: PHASE1
-
Repetitive Transcranial Magnetic Stimulation Therapy in Essential Tremor
NCT06145932 ·Status: RECRUITING ·Phase: NA
-
Non-invasive Brain Stimulation for the Treatment of Mild Cognitive Impairment in Parkinson's Disease
NCT06399731 ·Status: RECRUITING ·Phase: NA
-
Effects of rTMS and tDCS on Motor Function in Stroke
NCT01574989 ·Status: COMPLETED ·Phase: NA
-
Study of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease
NCT00029666 ·Status: COMPLETED ·Phase: PHASE2
-
Magnetic Stimulation for Parkinson Disease
NCT00029276 ·Status: COMPLETED ·Phase: PHASE1
-
rTMS Treatment in Vascular Parkinsonism
NCT03720691 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of Combined rTMS and Treadmill Training in People With Parkinson's Disease
NCT02701647 ·Status: COMPLETED ·Phase: NA
-
The Consciousness Variation of Deep Brain and Transcranial Magnetic Stimulation for Disorders of Consciousness Patients
NCT02667899 ·Status: UNKNOWN ·Phase: NA
-
The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's Disease
NCT02917122 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkinson's Disease
NCT06383247 ·Status: RECRUITING ·Phase: NA
-
Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current Stimulation
NCT03074812 ·Status: SUSPENDED ·Phase: NA
-
tDCS in Parkinson's Disease With Depression
NCT02315781 ·Status: TERMINATED ·Phase: NA
-
rTMS for Motor and Mood Symptoms of Parkinson's Disease
NCT01080794 ·Status: COMPLETED ·Phase: NA
-
Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localization) in Relieving Motor Symptoms of TD
NCT07173920 ·Status: RECRUITING ·Phase: NA